FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely obstetrics and perinatology, and can be used in predicting placental insufficiency associated with disorders in the fetal venous duct. To do this, dopplerometric indicators of blood flow velocity curves in the fetal venous duct are determined simultaneously with the first prenatal screening of pregnant women at 11-14 weeks. Then, at 19-21 weeks, all pregnant women, including those who were not included in the risk group during screening at 11-14 weeks, a dopplerometric study of the parameters of the curves of blood flow rates in the venous duct of the fetus is conducted. At the same time, all cases of fetal malformations or chromosomal pathology are excluded from further observation. After the second study, at the period of 19-21 weeks, a quantitative assessment of the curves of blood flow velocities in the venous duct is repeated and, based on the results of two studies, an increase in blood flow velocity in the late diastole phase and a decrease in the vein resistance index as a percentage are calculated. If the blood flow rate in the late diastole phase increases by less than 33%, and the value of the vein resistance index decreases by no more than 25%, then placental insufficiency and placenta-dependent pregnancy complications are predicted. If the blood flow rate of wave A increases by 33% or more, and the vein resistance index decreases by more than 25%, then an uncomplicated course of pregnancy is predicted.
EFFECT: method provides an objective and accurate prediction of placental insufficiency associated with disorders of placental-fetal blood flow in the first half of pregnancy, after the completion of remodeling of spiral arteries and the final formation of placental-fetal blood flow.
1 cl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTING INITIAL DISORDERS OF UTERINE CIRCULATION IN THE SECOND HALF OF PREGNANCY | 2006 |
|
RU2310379C1 |
METHOD FOR PREDICTING EARLY FETAL GROWTH RETARDATION ACCORDING TO PLACENTOMETRY AT 19-21 WEEKS OF GESTATION IN LOW-RISK PATIENTS | 2022 |
|
RU2795084C1 |
METHOD OF PREDICTING THE RISK OF FETAL GROWTH RESTRICTION IN THE FIRST HALF OF PREGNANCY | 2023 |
|
RU2803774C1 |
METHOD FOR PREDICTING FETAL GROWTH RETARDATION | 2022 |
|
RU2779406C1 |
METHOD OF HEMODYNAMIC PLACENTAL INSUFFICIENCY DIAGNOSTICS AT EARLY STAGE | 2006 |
|
RU2326599C1 |
METHOD OF DIAGNOSING ARTERIAL HYPERTENSION AND TRANSIENT HEART FAILURE IN 11-14 WEEK EMBRYO | 2011 |
|
RU2459583C1 |
METHOD OF PREDICTING PLACENTAL INSUFFICIENCY IN PREGNANT WOMEN WITH MIXED FORMS OF HYPERANDROGENY | 2010 |
|
RU2436513C1 |
METHOD FOR EARLY PREVENTION OF GESTATIONAL COMPLICATIONS | 2013 |
|
RU2530624C1 |
CHILD-BIRTH PERINATAL ISHEMIC-HYPOXIC CNS INVOLVEMENT PREDICTION METHOD | 2007 |
|
RU2354299C2 |
METHOD FOR PREDICTING PRIMARY PLACENTA INSUFFICIENCY SEVERITY DEGREE | 2005 |
|
RU2292552C2 |
Authors
Dates
2021-12-27—Published
2021-04-01—Filed